• Risk Management During A Pandemic: How Pfizer’s Quality Management System Fared

    Clinical Research News | Nothing quite tests a risk-based management approach like a global pandemic that few predicted. And for Pfizer’s Melissa Suprin, the COVID-19 pandemic was the first big test of the quality management system.

    Jan 26, 2021

  • Five Variants of Disease, When Patient Stratification Scores Fail, Studies for Long COVID: COVID-19 Updates

    Clinical Research News| The UK’s patient stratification score doesn’t hold up to scrutiny, Fauci and others encourage doctors to equip themselves to argue for vaccines, NIH launches a study of “Long COVID”, and more. Plus: Siemens, with German funding, sets up more COVID-19 treatment facilities for South Africa.

    Jan 22, 2021

  • Drugs Targeting Cellular Aging May Prove Useful For Numerous Conditions

    Clinical Research News | Fundamental aging processes appear to be root-cause contributors to multiple conditions, ranging from heart attacks and cancer to neurodegenerative disorders like Alzheimer’s disease. Now a series of clinical trials will look at whether senolytics— drugs targeting cellular aging—could affect many or perhaps all other aging mechanisms because they are interlinked.

    Jan 21, 2021

  • How the Pharma Industry Can Solve Common Clinical Trial Bottlenecks

    Clinical Research News | The race to develop a COVID-19 vaccine has shone a light on the sometimes complex process of getting a drug to market like never before, providing an opportune time to examine several common bottlenecks associated with clinical trials and what the industry can do to alleviate them.

    Jan 18, 2021